fp9 me-trap
Vaccineexperimental
Clinical trial activity
2 trials · 9 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Jun 1, 2004 (NCT00121823)
Timeline
2000s
- Jan 1, 2004
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Plasmodium falciparumImmunity, active
Plasmodium falciparum immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- fp9 me-trap
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00408668 | Phase 1/Phase 2 (Phase 2) | Aug 1, 2005 | Medical Research Council, Pevion Biotech Ltd, United States Army, University of Basel, University of Oxford |
| NCT00121823 | Phase 1/Phase 2 (Phase 2) | Jun 1, 2004 | Bill and Melinda Gates Foundation, Medical Research Council, The Gambia, University of London, University of Oxford, Wellcome Trust |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (9)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Oxford | Academic/Hospital | 2 | 1 | 1 | 2004 |
| Bill and Melinda Gates Foundation | Academic/Hospital | 1 | 0 | 1 | 2004 |
| Medical Research Council | Government | 1 | 0 | 1 | 2005 |
| Medical Research Council, The Gambia | Government | 1 | 0 | 1 | 2004 |
| Pevion Biotech Ltd | For profit | 1 | 0 | 1 | 2005 |
| United States Army | Government | 1 | 0 | 1 | 2005 |
| University of Basel | Academic/Hospital | 1 | 0 | 1 | 2005 |
| University of London | Academic/Hospital | 1 | 1 | 1 | 2004 |
| Wellcome Trust | Academic/Hospital | 1 | 0 | 1 | 2004 |
9 organizations
Page 1 / 1